Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 850 of 2228 entries
View as:

A Home-based Study Using Mobile Technology to Test Whether BI 1358894 is Effective in People With Depression

Phase: N/A Priority: Normal
NCT ID: NCT04423757 Org: User:
Start: 06/22/20 End: 05/08/22 Due: 05/08/23

Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3)

Phase: N/A Priority: Normal
NCT ID: NCT02580591 Org: User:
Start: 12/22/15 End: 09/20/17 Due: 09/20/18

A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00133185 Org: User:
Start: 03/31/04 End: 03/31/05 Due: 03/31/06

Bioavailability of Tipranavir/Ritonavir Paediatric Solution Compared to Tipranavir/Ritonavir Capsules in Healthy Female and Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02251158 Org: User:
Start: 10/31/03 End: - Due: -

Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study

Phase: N/A Priority: Normal
NCT ID: NCT02632747 Org: User:
Start: 05/10/16 End: 07/02/19 Due: 07/02/20

Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients.

Phase: N/A Priority: Normal
NCT ID: NCT00563381 Org: User:
Start: 01/31/08 End: - Due: -

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of AbGn-168 in Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00848055 Org: User:
Start: 12/31/08 End: - Due: -

A Study to Test How Zongertinib is Taken up in the Blood of People With and Without Liver Problems

Phase: N/A Priority: Normal
NCT ID: NCT06692322 Org: User:
Start: 01/15/25 End: 06/22/25 Due: 06/22/26

A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men

Phase: N/A Priority: Normal
NCT ID: NCT06916702 Org: User:
Start: 04/07/25 End: 03/12/26 Due: 03/12/27

Telmisartan/Hydrochlorothiazide (HCTZ) Fixed Dose Combination Compared to Its Monocomponents in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02176512 Org: User:
Start: 09/30/98 End: - Due: -

Safety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01955733 Org: User:
Start: 05/31/13 End: 11/07/16 Due: 11/07/17

Drug-drug Interaction (DDI) With a P-gp Inhibitor, Organic Anion Transporting Polypeptide OATP-inhibitor, Food Effect

Phase: N/A Priority: Normal
NCT ID: NCT03116893 Org: User:
Start: 04/19/17 End: 05/31/17 Due: 05/31/18

BI 113608 Administered as Tablets Twice Daily Over 4 Weeks in Patients With Chronic Obstructive Pulmonary Disease Associated With Chronic Bronchitis

Phase: N/A Priority: Normal
NCT ID: NCT01958008 Org: User:
Start: 09/30/13 End: 05/31/14 Due: 05/31/15

BI 2536 Second Line Monotherapy in SCLC

Phase: N/A Priority: Normal
NCT ID: NCT00412880 Org: User:
Start: 02/14/07 End: 06/30/08 Due: 06/30/09

WAL801CL (Epinastine Hydrochloride) Dry Syrup in Paediatric Perennial Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT02182544 Org: User:
Start: 06/30/01 End: - Due: -

Post Marketing Surveillance to Monitor the Safety and Efficacy of Metalyse® in Korean Patients With Acute Myocardial Infarction

Phase: N/A Priority: Normal
NCT ID: NCT02206646 Org: User:
Start: 02/28/03 End: - Due: -

Relative Bioavailability of 2 Oral Formulations of Nintedanib

Phase: N/A Priority: Normal
NCT ID: NCT02572752 Org: User:
Start: 08/31/15 End: 11/30/15 Due: 11/30/16

Spesolimab (BI 655130) Single Dose in Generalized Pustular Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02978690 Org: User:
Start: 12/19/16 End: 01/10/18 Due: 01/10/19

Relative Bioavailability of Single Oral Doses of Dabigatran Etexilate With or Without Oral Administration of Verapamil in Two Different Dosages in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02171533 Org: User:
Start: 06/30/08 End: - Due: -

Postmarketing Surveillance to Investigate the Safety and Efficacy Information of Alesion® Tablet

Phase: N/A Priority: Normal
NCT ID: NCT02238223 Org: User:
Start: 04/30/04 End: - Due: -

Long-term Safety Study of Open-label Pramipexole ER in Patients With Advanced PD

Phase: N/A Priority: Normal
NCT ID: NCT00577460 Org: User:
Start: 12/31/07 End: - Due: -

Investigation of Drug-drug Interaction of Dabigatran and Ticagrelor

Phase: N/A Priority: Normal
NCT ID: NCT01734772 Org: User:
Start: 11/30/12 End: 06/30/13 Due: 06/30/14

A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04958239 Org: User:
Start: 10/18/21 End: 11/19/28 Due: 11/19/29

A Study to Test Long-term Treatment With Spesolimab in People With a Skin Condition Disease Called Hidradenitis Suppurativa (HS) Who Took Part in a Previous Study With Spesolimab

Phase: N/A Priority: Normal
NCT ID: NCT06241573 Org: User:
Start: 05/08/24 End: 04/11/25 Due: 04/11/26

Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan) or Hydrochlorothiazide in the Management of Patients With Isolated Systolic Hypertension (ISH)

Phase: N/A Priority: Normal
NCT ID: NCT02175355 Org: User:
Start: 10/31/99 End: - Due: -